Rubio-Viqueira B, Jimeno A, Cusatis G, et al. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12:4652–61.
Rubio-Viqueira B, Hidalgo M. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clin Pharmacol Ther. 2009;85:217–21.
Kim MP, Evans DB, Wang H, et al. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc. 2009;4:1670–80.
Fu X, Guadagni F, Hoffman RM. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci USA. 1992;89:5645–9.
Tentler JJ, Tan AC, Weekes CD, et al. Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol. 2012;9:338–50.
Hidalgo M, Amant F, Biankin AV, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4:998–1013.
Siolas D, Hannon GJ. Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res. 2013;73:5315–9.
Rosfjord E, Lucas J, Li G, et al. Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncology. Biochem Pharmacol. 2014;91:135–43.
Williams Sa, Anderson WC, Santaguida MT, et al. Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century. Lab Invest. 2013;93:970–82.
Julien S, Merino-Trigo A, Lacroix L, et al. Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer. Clin Cancer Res. 2012;18:5314–28.
Hwang C-I, Boj SF, Clevers H, et al. Pre-clinical models of pancreatic ductal adenocarcinoma. J Pathol. 2016;238:197–204.
Voskoglou-nomikos T, Pater JL, Seymour L. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res. 2003;9:4227–39.
Fiebig HH, Maier A, Burger AM. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery. Eur J Cancer. 2004;40:802–20.
Johnson JI, Decker S, Zaharevitz D, et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer. 2001;84:1424–31.
Thomas RM, Truty MJ, Kim M, et al. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2015;22:1884–92.
Garrido-Laguna I, Uson M, Rajeshkumar NV, et al. Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer. Clin Cancer Res. 2011;17:5793–800.
DeRose YS, Wang G, Lin YC, et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med. 2011;17:1514–20.
Pegg DE. Principles of cryopreservation. Methods Mol Biol. 2015;1257:3–19.
Meryman HT. Cryoprotective agents. Cryobiology. 1971;8:173–83.
Mazur P. Cryobiology: the freezing of biological systems. Science. 1970;168:939–49.
Stylianou J, Vowels M, Hadfield K. Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB. Cytotherapy. 2006;8:57–61.
Thompson, M, Nemits, M, Ehrhardt, R "Rate-controlled cryopreservation and thawing of mammalian cells" Protocol Exchange (2011) https://doi.org/10.1038/protex.2011.224
Sorio C, Bonora A, Orlandini S, et al. Successful xenografting of cryopreserved primary pancreatic cancers. Virchows Arch. 2001;438:154–8.
Linnebacher M, Maletzki C, Ostwald C, et al. Cryopreservation of human colorectal carcinomas prior to xenografting. BMC Cancer. 2010;10:362.
Kuleshova LL, Wang XW, Wu YN, et al. Vitrification of encapsulated hepatocytes with reduced cooling/warming rates. Cryo Lett. 2004;25:241–54.
Polge C. Low-temperature storage of mammalian spermatozoa. Proc R Soc Lond B Biol Sci. 1957;147:498–508.
Isachenko V, Lapidus I, Isachenko E, et al. Human ovarian tissue vitrification versus conventional freezing: Morphological, endocrinological, and molecular biological evaluation. Reproduction. 2009;138:319–27.
Cui JH, Krüger U, Vogel I, et al. Intact tissue of gastrointestinal cancer specimen orthotopically transplanted into nude mice. Hepatogastroenterology. 1998;45:2087–96.
Alkema NG, Tomar T, Duiker EW, et al. Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods. Sci Rep. 2015;5:14495.
Bakhach J. The cryopreservation of composite tissues: Principles and recent advancement on cryopreservation of different type of tissues. Organogenesis. 2009;5:119–26.
Clarke DM, Yadock DJ, Nicoud IB, et al. Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution. Cytotherapy. 2009;11:472–9.
Buskirk RGVan, Snyder KK, Baust JG, et al. Cryopreservation: it’s not just about cell yield. BioProcess Int. 2005;3:64–74.
Sosef MN, Baust JM, Sugimachi K, et al. Cryopreservation of isolated primary rat hepatocytes: enhanced survival and long-term hepatospecific function. Ann Surg. 2005;241:125–33.
Corning. Corning® Matrigel® basement membrane matrix growth factor reduced phenol red free, 10 ml vial. Corning. 2013;356231:1–4.
Cassidy JW, Caldas C, Bruna A. Maintaining tumor heterogeneity in patient-derived tumor xenografts. Cancer Res. 2015;75:2963–8.
Kim MP, Truty MJ, Choi W. et al. Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy. Ann Surg Oncol. 2012;19(Suppl 3):S395–403.
Ramachandran H, Laux J, Moldovan I. et al. Optimal thawing of cryopreserved peripheral blood mononuclear cells use high-throughput human immune monitoring studies. Cells. 2012;1:313–24.
Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol. 1984;247(3 Pt 1):C125–C142.
Pegg DE, Diaper MP. On the mechanism of injury to slowly frozen erythrocytes. Biophys J. 1988;54:471–88.
Rall WF, Fahy GM. Ice-free cryopreservation of mouse embryos at -196C by vitrification. Nature. 1985;313:573–5.
Toner M, Cravalho EG, Karel M. Cellular-response of mouse oocytes to freezing stress—prediction of intracellular ice formation. J Biomech Eng. 1993;115:169–74.
Hubel A, Toner M, Cravalho EG, et al. Intracellular ice formation during the freezing of hepatocytes cultured in a double collagen gel. Biotechnol Prog. 1991;7:554–9.
Svalgaard JD, Haastrup EK, Reckzeh K, et al. Low-molecular-weight carbohydrate pentaisomaltose may replace dimethyl sulfoxide as a safer cryoprotectant for cryopreservation of peripheral blood stem cells. Transfusion. 2016;56:1088–95.
Gao D, Critser JK. Mechanisms of cryoinjury in living cells. ILAR J. 2000;41:187–96.
Mazur P, Leibo SP, Chu EHY. A two-factor hypothesis of freezing injury. Evidence from Chinese hamster tissue-culture cells. Exp Cell Res. 1972;71:345–55.
Reyes G, Villanueva A, Garcia C, et al. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice. Cancer Res. 1996;56:5713–9.
Bocsi J, Zalatnai A. Establishment and long-term xenografting of human pancreatic carcinomas in immunosuppressed mice: Changes and stability in morphology, DNA ploidy and proliferation activity. J Cancer Res Clin Oncol. 1999;125:9–19.
Murphy SJ, Hart SN, Halling GC, et al. Integrated genomic analysis of pancreatic ductal adenocarcinomas reveals genomic rearrangement events as significant drivers of disease. Cancer Res. 2016;76:749–62.